24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes

Clinical trial NCT00318656 · COMPLETED

Trial details

NCT number: NCT00318656
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Non-Insulin-Dependent Diabetes Mellitus

Start date: 2005-11-01
Primary completion: 2007-10-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.